Page last updated: 2024-09-03

fosamprenavir and dolutegravir

fosamprenavir has been researched along with dolutegravir in 1 studies

Compound Research Comparison

Studies
(fosamprenavir)
Trials
(fosamprenavir)
Recent Studies (post-2010)
(fosamprenavir)
Studies
(dolutegravir)
Trials
(dolutegravir)
Recent Studies (post-2010) (dolutegravir)
17455371,1281791,105

Protein Interaction Comparison

ProteinTaxonomyfosamprenavir (IC50)dolutegravir (IC50)
Chain A, PFV integraseHuman spumaretrovirus0.0517
Chain A, PFV integraseHuman spumaretrovirus0.0517
Chain A, PFV integraseHuman spumaretrovirus0.0517
Solute carrier family 22 member 2Homo sapiens (human)1.9
Integrase Human immunodeficiency virus 10.0414

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borland, J; Chen, S; Peppercorn, A; Piscitelli, SC; Song, I; Wajima, T1

Trials

1 trial(s) available for fosamprenavir and dolutegravir

ArticleYear
Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Adult; Area Under Curve; Carbamates; Drug Administration Schedule; Drug Interactions; Female; Furans; Healthy Volunteers; Heterocyclic Compounds, 3-Ring; HIV Integrase; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Male; Organophosphates; Oxazines; Piperazines; Pyridones; Ritonavir; Sulfonamides

2014